Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Osteoporosis
Is elevated bone specific alkaline phosphatase an absolute contraindication to teriparatide?
Related Questions
What treatment options would you consider for a young patient with limited mobility, low bone mass and multiple vertebral compression fractures who is on dialysis for advanced kidney disease?
Is it safe to combine Prolia with other immunosuppressants?
How do you manage hepatotoxicity thought to be related to Romosozumab use?
How should we interpret DXA scans in patients with Ankylosing Spondylitis who have ankylosis of the spine?
Which fracture sites outside of the classical spine and hip are considered to be osteoporotic fractures even in the absence of a bone density diagnosis?
Are there any concerns with using denosumab in a patient with chronic hepatitis B infection on antiviral therapy?
Would you continue zolendronic acid infusions if the bone density decreases significantly in year two?
How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
How do you determine osteoporosis treatment response when patients have discrepant DEXA scan results during monitoring (eg improved BMD of the hip and spine but worsening BMD of the femoral neck)?
Would you stop romosozumab if a patient developed mild asymptomatic hypocalcemia while on treatment?
